RITUXIMAB MAINTENANCE AFTER AUTOLOGOUS TEM CELL TRANSPLANTATION PROLONGS SURVIVAL IN YOUNGER PATIENTS WITH MANTLE CELL LYMPHOMA: FINAL RESULTS OF THE LYMA TRIAL OF THE LYSA/GOELAMS GROUP
EHA Learning Center, Steven LE GOUILL, 181392
POLA-R-CHP: POLATUZUMAB VEDOTIN COMBINED WITH RITUXIMAB, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE FOR PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE LARGE B-CELL LYMPHOMA
EHA Learning Center, Hervé Tilly, 181393
DEEP MOLECULAR RESPONSE TO GILTERITINIB IMPROVES SURVIVAL IN FLT3 MUTATION-POSITIVE RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
EHA Learning Center, Altman Jessica, 181397
Updates in the frontline setting and relapse MM from IMW 2017: An expert roundtable discussion
EHA Learning Center, Delivered by Janssen, 183453
LOW MYBL2 EXPRESSION OBSERVED IN MYELODYSPLASTIC SYNDROME PATIENTS WITH WORSE PROGNOSIS IS ASSOCIATED WITH ALTERED DNA REPAIR MECHANISMS IN HAEMATOPOETIC STEM CELLS
EHA Learning Center, Paloma García, 181406
A NOVEL GENETIC AND MORPHOLOGIC PHENOTYPE OF ARID2-MEDIATED MYELODYSPLASTIC SYNDROMES.
EHA Learning Center, Hideki Makishima, 181407
GENETIC ALTERATIONS INVOLVING PROGRAMMED DEATH LIGANDS IN EPSTEIN-BARR VIRUS-ASSOCIATED LYMPHOMAS
EHA Learning Center, Keisuke Kataoka, 181411
FOXO1 CONTROL CD20 EXPRESSION AND INFLUENCE B-CELL LYMPHOMA RESPONSE TO RITUXIMAB-BASED IMMUNOTHERAPY
EHA Learning Center, Michal Dwojak, 181412
FUNCTIONAL PROTEOMICS IDENTIFIES SETD2 AS A CRITICAL EFFECTOR OF MLL FUSION PROTEINS TO SAFEGUARD GENOMIC INTEGRITY.
EHA Learning Center, Anna Skucha, 181420
CEBPA-MUTANT ACUTE MYELOID LEUKEMIA IS SENSITIVE TO SMALL-MOLECULE-MEDIATED INHIBITION OF THE MENIN-MLL INTERACTION
EHA Learning Center, Luisa Schmidt, 181421
STEP-WISE REPROGRAMMING OF ENDOTHELIAL CELLS INTO IMMUNE-COMPETENT HEMATOPOIETIC STEM CELLS
EHA Learning Center, Jose Gabriel Barcia Duran, 181424
MARROW MESENCHYMAL STEM CELLS RESCUE BONE MARROW ENDOTHELIAL CELLS SUFFERING CHEMOTHERAPY STRESS BY TRANSFERRING MITOCHONDRIA THROUGH NANOTUBES
EHA Learning Center, Yonghuai Feng, 181425
WILMS' TUMOR 1 (WT1) RNA-ELECTROPORATED DENDRITIC CELL VACCINATION AS POST-REMISSION TREATMENT TO PREVENT OR DELAY RELAPSE IN ACUTE MYELOID LEUKEMIA: FINAL RESULTS OF A PHASE II STUDY IN 30 PATIENTS
EHA Learning Center, Zwi Berneman, 181428
FIRST-IN-HUMAN MULTICENTER STUDY OF BB2121 ANTI-BCMA CAR T CELL THERAPY FOR RELAPSED/REFRACTORY MULTIPLE MYELOMA: UPDATED RESULTS
EHA Learning Center, Yi Lin, 181429
All children with sickle cell anemia and an HLA identical sibling should be offered hematopoietic stem cell transplantation
EHA Learning Center, Mariane de Montalembert, 192914
Is transplantation still needed in the era of immunotherapy?
EHA Learning Center, Anna Sureda, 184415
Clonal Evolution in AML
EHA Learning Center, KH Metzeler, 192901
Harnessing T-cell mediated anti-leukemic effect: From unmanipulated donor T-cells to tumor-specific and  genetically modified T-cells
EHA Learning Center, Hans-Jochem Kolb, 184419
Immunosenescence: When And How To Vaccinate Older Patients With Malignant Hemopathies?
EHA Learning Center, Raphael Solana, 184422
RBC hydration defects
EHA Learning Center, Carlo Brugnara, 184429
Immune checkpoint inhibitors
EHA Learning Center, Anas Younes, 184414
Engineering NK cells for the treatment of hematologic malignancies
EHA Learning Center, Katy Rezvani, 184425
The long journey of donor search: From sibling to MUD to cord and haplo transplantation
EHA Learning Center, Eliane Gluckman, 184418
Immunosenescence Or Why Are Older Patients More Sensitive To Malignancies?
EHA Learning Center, Tamas Fulop, 184421
Stomatocytosis and allied disorders
EHA Learning Center, Immacolata Andolfo, 184428
Novel aspects of diagnosis of VT
EHA Learning Center, Menno Huisman, 192909
Microenvironment in lymphoma
EHA Learning Center, Georg , 184413
From dogs to humans... The 60 year long road of allogeneic stem cell transplantation
EHA Learning Center, Rainer Storb, 184417
Elderly task force in hematology: Chair
EHA Learning Center, Dominique Bron, 184420
Functional diversification of human NK cells
EHA Learning Center, Kalle Malmberg, 184424
RBC membrane transport in health and disease
EHA Learning Center, Giel Bosman, 184427
PEG Filgrastim in SCN
EHA Learning Center, Francesca Fioredda, 184410
Treatment of extranodal marginal zone B-cell lymphomas
EHA Learning Center, Markus Raderer, 184394
Emerging treatments for classical myeloproliferative neoplasms
EHA Learning Center, Claire Harrison, 184398
Although ALL is highly curable with conventional chemotherapy, novel therapeutic approaches are still needed to improve outcomes for high-risk or relapsed ALL, especially in adults.Immunotherapeutic approaches have significantly improved the outcome of R
EHA Learning Center, Josep-Maria Ribera, 184402
The 100.000 genomes project
EHA Learning Center, Willem Ouwehand, 184406
Treatment and sequence in multiple myeloma
EHA Learning Center, Xavier Leleu, 192931
Treatment should be started in every patient with high risk smoldering multiple myeloma
EHA Learning Center, María-Victoria Mateos, 192932
First-line therapy for CLL in 2017
EHA Learning Center, Alessandra Tedeschi, 192933
Diagnosis and management of Von Willebrand Disease
EHA Learning Center, Giancarlo Castaman, 192934
RBC membrane transport in health and disease
EHA Learning Center, Giel Bosman, 192935
The long journey of donor search: From sibling to MUD to cord and haplo transplantation
EHA Learning Center, Eliane Gluckman, 192936
Should low risk MDS be transplanted?
EHA Learning Center, Nicolaus Kröger, 192937
Stop of TKI in CML
EHA Learning Center, Juan Luis Steegmann, 192938
Highlights in MPN
EHA Learning Center, Claire Harrison, 192939
Highlights in ALL
EHA Learning Center, Ajay Vora, 192940
Neurological complications of sickle cell disease
EHA Learning Center, Fenalla Kirkham, 192941
Diagnosis and management of rare bleeding disorders & gene therapy
EHA Learning Center, Gili Kenet, 192942
PET-CT as biomarker for response in Lymphoma?/ Interim-PET as a valid biomarker for early response in malignant lymphoma; when to perform and how to assess
EHA Learning Center, Josee Zijlstra, 192943
Top 3 AML
EHA Learning Center, Gert Ossenkoppele, 192944
Anticoagulation in the frail patient / Anticoagulation in the elderly/frail patient (25min)
EHA Learning Center, Kamphuisen Pieter, 192945
Neutrophil extra cellular traps (NET)
EHA Learning Center, Jean Donadieu, 184409
Update on follicular lymphoma: Time beyond chemotherapy?
EHA Learning Center, Kai Hübel, 184393
Targeting specific mutations in MPN
EHA Learning Center, Ann Mullally, 184397
Immunotherapy of ALL from biology to the clinic and back
EHA Learning Center, Terry Fry, 184401
Syndromes predisposing to hematological malignancies
EHA Learning Center, Christian Kratz, 184405
Drivers of leukemogenesis in congenital neutropenias
EHA Learning Center, Karl Welte, 184408
Molecular profiling of indolent lymphoma
EHA Learning Center, STEFANO PILERI, 184392
Molecular genetics in MPN
EHA Learning Center, Alessandro M. Vannucchi, 184396
Balance of efficacy vs toxicity in treatment of childhood ALL: Time for dose reductions?
EHA Learning Center, Ajay Vora, 184400
Diagnosis of inherited bone marrow failure and myelodysplastic syndromes
EHA Learning Center, Akiko Shimamura, 184404
EHA22 Educational Updates in Hematology
EHA Learning Center, EHA annual congress, 186248
Syndromes predisposing to hematological malignancies
EHA Learning Center, Christian Kratz, 185019
Diagnosis of inherited bone marrow failure and myelodysplastic syndromes
EHA Learning Center, Akiko Shimamura, 185020
Immune checkpoint inhibitors
EHA Learning Center, Anas Younes, 185023
Is transplantation in lymphoma still needed in the era of immunotherapy?
EHA Learning Center, Anna Sureda, 185024
Novel approaches to eradicate CML stem cells
EHA Learning Center, Mhairi Copland, 185025
Molecular work up and monitoring of CML patients
EHA Learning Center, NCP Cross, 185026
How to treat CML in 2017
EHA Learning Center, Andreas Hochhaus, 185027
GvHD prophylaxis and treatment, new modalities
EHA Learning Center, Robert Zeiser, 185028
The role of the intestinal microbiota in graft-versus-host disease
EHA Learning Center, Marcel van den Brink, 185029
Balancing Graft versus Leukemia and Graft versus Host responses
EHA Learning Center, Fred Falkenburg, 185030
Genome editing in hemoglobinopathies
EHA Learning Center, Mitch Weiss, 185031
Iron chelation in hemoglobinopathies
EHA Learning Center, Vip , 185032
Neurological complications of sickle cell disease
EHA Learning Center, Fenalla Kirkham, 185033
Biological and clinical relevance of fibrin clot structure
EHA Learning Center, Nicola Mutch, 185034
Diagnosis and management of DIC and primary hyperfibrinolysis
EHA Learning Center, Alessandro Squizzato, 185035
Rare bleeding disorders - Diagnosis and treatment
EHA Learning Center, Gili Kenet, 185036
Prioritizing therapies in CLL
EHA Learning Center, Clemens Wendtner, 185039
The effects of chemotherapy and radiotherapy on reproduction
EHA Learning Center, William Hamish Wallace, 185040
Fertility preservation in female patients
EHA Learning Center, Marie-Madeline Dolmans, 185041
Fertility preservation in pre-pubertal and adult males
EHA Learning Center, Rod Mitchell, 185042
Cross-talk between inflammation and coagulation
EHA Learning Center, Thomas Renné, 185043
Novel aspects in the diagnostic management of deep vein thrombosis and pulmonary embolism
EHA Learning Center, Menno Huisman, 185044
Controversies in treating small clots in the leg and in the lung
EHA Learning Center, Sebastian Schellong, 185045
Clonal evolution in MDS
EHA Learning Center, Joop Jansen, 185046
The role of immune response in MDS pathophysiology
EHA Learning Center, Ghulam Mufti, 185047
Indications for transplantation in myelodysplastic syndromes (MDS)
EHA Learning Center, Matteo Giovanni Della Porta, 185048
Molecular diagnostics in AML
EHA Learning Center, Lars Bullinger, 185049
Targeting mutated FLT3 in AML
EHA Learning Center, Mark Levis, 185050
3+7 and beyond
EHA Learning Center, Norbert Vey, 185051
Transferrin and TfR1 in co-regulation of erythropoiesis and iron metabolism
EHA Learning Center, Yelena Ginzburg, 185055
Iron overload before, during and after bone marrow transplantation
EHA Learning Center, Emanuele Angelucci, 185056
Heat Shock Protein 70 (HSP70), one of the major key factors in Diamond-Blackfan anemia
EHA Learning Center, Lydie Da Costa, 185057
The biological basis of aggressive lymphoma
EHA Learning Center, Elias Campo, 185058
Relapsed aggressive lymphoma: Can we optimize the therapy
EHA Learning Center, Gilles Salles, 185059
Treatment of aggressive lymphomas focused on elderly patients
EHA Learning Center, Michael Pfreundschuh, 185060
Immunopathology of multiple myeloma
EHA Learning Center, Nikhil Munshi, 185061
Genetic classification of myeloma for prognostication and treatment selection
EHA Learning Center, Hervé Avet-Loiseau, 185062
New approaches to myeloma treatment in 2017
EHA Learning Center, Jesus F. San Miguel, 185063